Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP−induced Parkinson's disease

[1]  C. Chu Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson’s disease , 2019, Neuroscience Letters.

[2]  David S. Park,et al.  Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons , 2018, The Journal of Biological Chemistry.

[3]  S. Gygi,et al.  Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics. , 2018, Molecular cell.

[4]  G. Deuschl,et al.  Analysis of blood-based gene expression in idiopathic Parkinson disease , 2017, Neurology.

[5]  R. Takahashi,et al.  ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease , 2017, EBioMedicine.

[6]  G. Lazzari,et al.  Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells , 2017, Molecular and Cellular Biochemistry.

[7]  K. Fukunaga,et al.  Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation , 2015, Brain Research.

[8]  N. Hattori,et al.  Utility of the Japanese version of the 9-item Wearing-off Questionnaire , 2015, Clinical Neurology and Neurosurgery.

[9]  D. Miljković,et al.  Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  F. Berardi,et al.  Live imaging reveals a new role for the sigma-1 (σ 1) receptor in allowing microglia to leave brain injuries , 2015, Neuroscience Letters.

[11]  Liang Tong,et al.  Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations , 2015, Nature.

[12]  R. Youle,et al.  The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.

[13]  K. Fukunaga,et al.  Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis. , 2014, Biochimica et biophysica acta.

[14]  Y. Ohizumi,et al.  Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice , 2014, Neuroscience.

[15]  A. Albanese,et al.  Early DEtection of wEaring off in Parkinson disease: the DEEP study. , 2014, Parkinsonism & related disorders.

[16]  Ja-Kyeong Lee,et al.  Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain , 2014, Neuroscience Letters.

[17]  K. Fukunaga,et al.  Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress , 2013, Neuroscience.

[18]  Marc Flajolet,et al.  Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems , 2013, Trends in Neurosciences.

[19]  R. Bhattacharya,et al.  Neuroprotective effects of alpha-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice , 2013, Human & experimental toxicology.

[20]  A. Cumaoğlu,et al.  Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: Consequences of treatment with antioxidant pyridoindole , 2013, Experimental Gerontology.

[21]  T. Zeng,et al.  Elevation of 4-hydroxynonenal and malondialdehyde modified protein levels in cerebral cortex with cognitive dysfunction in rats exposed to 1-bromopropane. , 2013, Toxicology.

[22]  K. Fukunaga,et al.  Stimulation of σ1-receptor restores abnormal mitochondrial Ca²⁺ mobilization and ATP production following cardiac hypertrophy. , 2013, Biochimica et biophysica acta.

[23]  Li-wen Chang,et al.  Sodium Pyruvate Reduced Hypoxic-Ischemic Injury to Neonatal Rat Brain , 2012, Pediatric Research.

[24]  M. Zarrindast,et al.  Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus , 2012, Behavioural Brain Research.

[25]  K. Fukunaga,et al.  Reduced calcium/calmodulin‐dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP‐treated mice , 2012, Journal of neurochemistry.

[26]  M. Cammarota,et al.  D1/D5 dopamine receptors modulate spatial memory formation , 2012, Neurobiology of Learning and Memory.

[27]  Y. Pak,et al.  Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson’s Disease , 2011, The Journal of Immunology.

[28]  R. Roesler,et al.  Modulatory influence of dopamine receptors on consolidation of object recognition memory , 2011, Neurobiology of Learning and Memory.

[29]  H. Toresson,et al.  The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. , 2011, Brain : a journal of neurology.

[30]  M. Watkins,et al.  Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion. , 2011, The Journal of trauma.

[31]  R. Sutton,et al.  Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat , 2010, Experimental Neurology.

[32]  José María Delgado-García,et al.  Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice , 2010, The Journal of Neuroscience.

[33]  M. Fink,et al.  The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. , 2010, Biochemical pharmacology.

[34]  Jun Chen,et al.  Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms , 2010, Neurobiology of Disease.

[35]  M. Tarnopolsky,et al.  The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[37]  A. Trifunovic,et al.  The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging , 2009, Aging.

[38]  T. Seike,et al.  Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease , 2009, PloS one.

[39]  A. Sepulveda,et al.  Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis , 2009, Journal of leukocyte biology.

[40]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[41]  J. Jeon,et al.  Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. , 2008, Free radical biology & medicine.

[42]  Eduardo D. Martín,et al.  D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus. , 2008, Cerebral cortex.

[43]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[44]  T. James,et al.  Exogenous Ethyl Pyruvate versus Pyruvate during Metabolic Recovery after Oxidative Stress in Neonatal Rat Cerebrocortical Slices , 2007, Anesthesiology.

[45]  N. Fuku,et al.  Therapeutic potential of pyruvate therapy for mitochondrial diseases. , 2007, Mitochondrion.

[46]  Ann Saada,et al.  Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc. , 2007, Methods in cell biology.

[47]  C. Mannella,et al.  Structural and functional features and significance of the physical linkage between ER and mitochondria , 2006, The Journal of cell biology.

[48]  N. Lemon,et al.  Dopamine D1/D5 Receptors Gate the Acquisition of Novel Information through Hippocampal Long-Term Potentiation and Long-Term Depression , 2006, The Journal of Neuroscience.

[49]  T. Dawson,et al.  Diagnosis and treatment of Parkinson disease: molecules to medicine. , 2006, The Journal of clinical investigation.

[50]  K. Nair,et al.  Decline in skeletal muscle mitochondrial function with aging in humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Berry,et al.  Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. , 2004, The Journal of thoracic and cardiovascular surgery.

[52]  R. G. Kemp,et al.  Allosteric regulatory properties of muscle phosphofructokinase , 2004, Molecular and Cellular Biochemistry.

[53]  K. Fukunaga,et al.  The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1h-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia , 2003, Neuroscience.

[54]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[55]  K. Soliman,et al.  Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro , 2003, Neuroscience Letters.

[56]  K. Tracey,et al.  Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Koh,et al.  Protection by Pyruvate against Transient Forebrain Ischemia in Rats , 2001, The Journal of Neuroscience.

[58]  P. Esselman,et al.  Oxidative capacity and ageing in human muscle , 2000, The Journal of physiology.

[59]  K. Nair,et al.  Effects of Aging on Mitochondrial DNA Copy Number and Cytochromec Oxidase Gene Expression in Rat Skeletal Muscle, Liver, and Heart* , 2000, The Journal of Biological Chemistry.

[60]  W. Tatton,et al.  Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.

[61]  G. Rutter,et al.  Integrating cytosolic calcium signals into mitochondrial metabolic responses , 1998, The EMBO journal.

[62]  K. Matsuno,et al.  Activation of σ 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures , 1998, Neurochemistry International.

[63]  R. Depue,et al.  Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. , 1998, Cerebral cortex.

[64]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[65]  M. Beal,et al.  Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects , 1997, Annals of neurology.

[66]  R. Quirion,et al.  Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  P. Goldman-Rakic,et al.  Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[68]  H. Eichenbaum,et al.  The hippocampus--what does it do? , 1992, Behavioral and neural biology.

[69]  F. Di Virgilio,et al.  Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. , 1991, The Biochemical journal.

[70]  F. Di Virgilio,et al.  Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. , 1990, Journal of immunology.

[71]  M. Sitkovsky,et al.  Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. , 1990, The Journal of biological chemistry.

[72]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[73]  W. Schaper,et al.  Biochemical mechanism of infarct size reduction by pyruvate. , 1981, Cardiovascular research.

[74]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[75]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[76]  O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.

[77]  R. W. Korff PYRUVATE-C14, PURITY AND STABILITY. , 1964 .

[78]  Webb Jl,et al.  Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956 .

[79]  C. M. Montgomery,et al.  Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956, The Journal of biological chemistry.